Figure 1 — Modulation of Coenzyme Q10 content and oxidative status in human dermal fibroblasts using HMG-CoA reductase inhibitor over a broad range of concentrations. From mitohormesis to mitochondrial dysfunction and accelerated aging | Aging

Navigate

Submit an Article

Research Paper|Volume 11, Issue 9|pp. 2565–2582

Modulation of Coenzyme Q₁₀ content and oxidative status in human dermal fibroblasts using HMG-CoA reductase inhibitor over a broad range of concentrations. From mitohormesis to mitochondrial dysfunction and accelerated aging

Back to articleFigure 1(1 of 7)

100%

Figure 1.The mevalonate pathway.